Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1994-08-08
1996-03-05
Warden, Jill
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 3, 514 4, C07K 1464, C07K 900, A61K 3800
Patent
active
054968038
ABSTRACT:
A process for the long-term modification and regulation of lipid metabolism--generally to reduce obesity, insulin resistance, and hyperinsulinemia (the three hallmarks of Type II diabetes)--by injections into the bloodstream of a vertebrate, animal or human, of prolactin, or both prolactin and a glucocorticosteroid. The injections are made over a limited period at a time of day dependent on the normal circadian rhythm of fat and lean members of a similar species. Decreases (or increases) in body fat deposits result by treatment of an obese species (lean species) on a daily timed sequence based on circadian rhythms of the peak prolactin, or peak prolactin and peak glucocorticosteroid, blood level established for lean members (or obese members) of a similar species. Insulin resistance, and hyperinsulinemia can also be controlled in humans on a long-term basis by treatment corresponding to that of the treatment for obesity. The short-term daily injections reset hormonal timing in the neural centers of the brain to produce long-term effects.
REFERENCES:
Meier et al., Biology of Reproduction 8:400-410, 1973.
Meier et al., General and Comparative Endocrinology 26:253-258, 1975.
Meier et al., General and Comparative Endocrinology Suppl. 3:499-508, 1972.
Barnett, Post Graduate Medical J. 56:11-14, 1980.
Meier et al., Current Ornithology 2:303-343, 1984.
Cincotta, J. Endocrinol. 106:173-176, 1984.
Wilson, Chrono. Bio. Int. 6:113-121, 1989.
Cincotta et al., J. Endocrinol. 120:385-391, 1989.
Albert H. Meier and Albert C. Russo, Circadian Organization of the Avian ual Cycle, pp. 316, 326-T, 328-9, 330, 1973.
Christopher J. deSouza and Albert G. Meier, Circadian and Seasonal Variations of Plasma Insulin and Cortisol Concentrations in the Syrian Hamster, Mesocricetus Auratus, vol. 4, No. 2, pp. 141-151, 1987 Chronobiology International.
Albert H. Meier, Temporal Synergism of Prolactin and Adrenal Steroids, General and Comparative Endocrinology Supplement 3, 499-508 (1972).
Albert H. Meier and John T. Burns, Circadian Hormone Rhythms in Lipid Regulation, Amer. Zool., 16:649-659 (1976).
E. Bonora, C. Coscelli and U. Butturini, Relationship between Insulin Resistance, Insulin Secretion and Insulin Metabolism in Simple Obesity, International Journal of Obesity (1985) 9, 307-312.
C. Ronald Kahn, M.D., Insulin Resistance: A Common Feature of Diabetes Mellitus, The New England Journal of Medicine, Jul. 24, 1986.
Mayer B. Davidson, MD., Review: Pathogenesis of Type 2 Diabetes Mellitus: An Interpretation of Current Data, The American Journal of the Medical Sciences Jul. 1986 vol. 292 No. 1.
Joseph A. Truglia, M.D., James N. Livingston, D.V.M., Ph.D., Dean H. Lockwood, M.D., Insulin Resistance: Receptor and Post Binding Defects in Human Obesity and Non-Insulin-Dependent Mellitus, The American Journal of Medicine vol. 979 (Suppl 2B) Aug. 23, 1985.
Steven M. Haffner, M.D., Michael P. Stern, M.D., Helen P. Hazuda, Ph.D., Jacqueline A. Pugh, M.D., and Judith K, Patterson, Ph.D. Hyperinsulinemia in a Population at High Risk for Non-Insulin-Dependent Diabetes Mellitus, The New England Journal of Medicine, Jul. 24, 1986.
Cincotta et al., J. of Endocrinology, 120, 385-391, 1989.
Odedra et al., Chem. Absts., 97, 79, 1982, entry No. 104402z.
Iida, Chem. Absts., 75, 82, 1971, entry No. 30764t.
Cincotta et al. Chronobiology International, vol. 10, No. 4, pp. 244-258 (1993).
Ojasoo et al. Steroid Hormone Receptors in Comprehensive Medicinal Chemistry, Hansch et al., eds., vol. 3, pp. 1213-1218 (1990).
Cincotta Anthony H.
Meier Albert H.
Louisiana State University and Agricultural and Mechanical Colle
Touzeau Lynn
Warden Jill
LandOfFree
Process for the long term reduction of body fat stores, insulin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Process for the long term reduction of body fat stores, insulin , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for the long term reduction of body fat stores, insulin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1413018